002644 佛慈製藥
按盤價 
6.600 +0.250 (+3.937%)
6.600 +0.250 (+3.937%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.048 | 3.879 | 6.519 | 5.835 | 6.998 |
| 總資產報酬率 ROA (%) | 0.727 | 2.617 | 4.383 | 3.936 | 4.512 |
| 投入資產回報率 ROIC (%) | 0.986 | 3.578 | 5.991 | 5.381 | 6.508 | 邊際利潤分析 |
| 銷售毛利率 (%) | 31.096 | 31.062 | 29.280 | 27.292 | 24.757 |
| 營業利潤率 (%) | 8.384 | 7.160 | 13.732 | 13.742 | 19.510 |
| 息稅前利潤/營業總收入 (%) | 8.076 | 6.591 | 11.809 | 12.474 | 17.881 |
| 淨利潤/營業總收入 (%) | 6.795 | 5.857 | 10.490 | 11.438 | 16.123 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 126.284 | 102.844 | 70.529 | 58.429 | 20.586 |
| 價值變動淨收益/利潤總額(%) | -11.544 | -5.501 | -0.992 | -0.766 | -3.103 |
| 營業外收支淨額/利潤總額(%) | -1.755 | -2.000 | -9.509 | -1.397 | 0.141 | 償債能力分析 |
| 流動比率 (X) | 2.709 | 2.649 | 2.403 | 2.760 | 2.495 |
| 速動比率 (X) | 1.888 | 1.858 | 1.734 | 2.070 | 1.884 |
| 資產負債率 (%) | 29.295 | 30.049 | 33.195 | 30.806 | 0.335 |
| 帶息債務/全部投入資本 (%) | -10.069 | -8.628 | -8.598 | -12.442 | -14.002 |
| 股東權益/帶息債務 (%) | -944.317 | -1,078.540 | -1,063.428 | -742.830 | -657.295 |
| 股東權益/負債合計 (%) | 238.207 | 229.753 | 198.687 | 222.825 | 197.741 |
| 利息保障倍數 (X) | -49.576 | -15.412 | -16.152 | -11.559 | -10.794 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 105.846 | 103.742 | 110.313 | 95.917 | 99.666 |
| 存貨周轉天數 (天) | 178.451 | 164.541 | 151.898 | 156.584 | 195.211 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 05/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
